Blood Glucose Monitoring System Market Size 2025-2029
The blood glucose monitoring system market size is forecast to increase by USD 10.1 billion, at a CAGR of 10.0% between 2024 and 2029.
The availability of reimbursement for blood glucose monitoring devices serves as a important driver, making advanced technologies more accessible to a wider patient population. This financial support aligns with the rising demand for continuous glucose monitoring (CGM) market systems, which offer superior patient convenience and real-time data compared to traditional methods. As these devices become more affordable through better insurance coverage, their adoption is increasing, shaping the future of the diabetes management devices market by enabling more proactive and data-driven approaches to glycemic control. These systems are becoming integral to modern patient monitoring equipment.Despite these positive developments, the market's full potential is constrained by a significant rate of undiagnosed diabetes, particularly in emerging economies. This lack of awareness and limited access to structured screening programs means a large portion of the potential user base remains unaddressed. This challenge affects the uptake of all monitoring products, from basic self-monitoring blood glucose strips to advanced systems. The low diagnosis rate hinders early intervention and the broad-scale implementation of effective diabetes management, thereby moderating the growth trajectory of the home blood testing devices market and overall industry expansion.
What will be the Size of the Blood Glucose Monitoring System Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019 - 2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The global blood glucose monitoring system market is undergoing a significant transformation, driven by the shift from traditional self-monitoring systems to advanced continuous glucose monitoring (CGM) market technologies. This evolution is redefining glycemic management by providing real-time data streams that enable more proactive and personalized care. The integration of biosensor technology into wearable and less invasive formats is enhancing patient convenience and treatment adherence, making daily management less burdensome. These advancements are pivotal in the broader patient monitoring equipment market.Data connectivity and digital health ecosystems are becoming central to the market's development. Monitoring devices are increasingly serving as key data points within larger diabetes management devices market platforms that utilize predictive algorithms and AI to offer actionable insights. This trend supports remote patient monitoring and facilitates better communication between patients and healthcare providers. The ongoing pursuit of non-invasive glucose monitoring devices continues to be a key area of innovation, promising to further revolutionize the user experience and expand market accessibility.
How is this Blood Glucose Monitoring System Industry segmented?
The blood glucose monitoring system industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019 - 2023 for the following segments.
- Product
- Self monitoring
- Continuous glucose monitoring devices
- End-user
- Hospitals
- Home care
- Diagnostic centers
- Indication
- Type-2 diabetes population
- Type-1 diabetes population
- Geography
- North America
- Europe
- Germany
- UK
- France
- Italy
- The Netherlands
- Spain
- Asia
- Rest of World (ROW)
By Product Insights
The self monitoring segment is estimated to witness significant growth during the forecast period.
The self-monitoring segment remains a substantial part of the market, primarily driven by the high global prevalence of diabetes. These devices are well-established, and their portability, accuracy, and ease of use make them a preferred option for many patients, particularly for routine checks of glycemic levels. In 2023, this segment accounted for approximately 66% of the market, underscoring its foundational role in diabetes care. Demand is sustained by its cost-effectiveness compared to more advanced systems.
Innovation continues within this mature segment, with a significant focus on enhancing patient convenience and reducing discomfort. Research and development efforts are geared toward non-invasive technologies, such as those using ultrasound waves to measure glucose levels without piercing the skin. This pursuit of needle-free self-monitoring systems reflects a clear industry direction toward improving the user experience and encouraging greater treatment adherence by removing the pain and hassle associated with traditional fingerstick methods.
Request Free Sample
The Self monitoring segment was valued at USD 7.4 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 44.5% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
Request Free Sample
The North America market is characterized by steady growth, driven by an increase in technological advances and a high incidence of diabetes. Favorable government and private initiatives aimed at creating awareness are significant drivers. For instance, type 2 diabetes accounted for around 90% to 95% of all diabetes cases in one of the major countries in this region, creating a large, sustained demand for BGM systems. The presence of an aging population and rising obesity levels further contributes to this trend in North America.
The region, especially its largest country, is a primary market for BGM systems, benefiting from a high level of population awareness that leads to regular testing and check-ups. This demand is met by numerous reputable companies based in North America. Continuous innovation, such as the introduction of new technologies for monitoring glucose levels and an increasing number of regulatory approvals for new products, supports the accelerating growth momentum. This dynamic ensures that the North America market remains at the forefront of the industry.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The global blood glucose monitoring market is rapidly evolving, driven by innovations in real-time continuous glucose monitoring systems and advancements in glucose biosensor materials. The development of wearable sensors for diabetes management is a key trend, with significant focus on implantable long-term glucose sensors and emerging non-invasive blood glucose measurement techniques. These technologies are critical for improving glycemic control in type 2 diabetes and are increasingly utilized for glucose monitoring for gestational diabetes. The market is also seeing a shift towards more convenient solutions, such as factory-calibrated glucose monitoring sensors, which enhance the user experience design for diabetes technology. The successful integration with automated insulin delivery systems is creating closed-loop solutions, fundamentally changing patient care.The growing volume of data from these devices highlights the crucial role of AI in personalized diabetes care, employing predictive algorithms for hypoglycemia prevention and enabling sophisticated ambulatory glucose profile data analysis. However, significant challenges in CGM data interpretation remain. Providers and patients are increasingly leveraging digital platforms for remote patient monitoring, which positively influences the impact of glucose monitoring on patient behavior. On the business side, the cost-effectiveness of continuous glucose monitoring is a major factor influencing adoption, alongside the complex reimbursement landscape for CGM devices. Furthermore, ensuring robust cybersecurity for connected glucose monitors is paramount for patient safety, while traditional point-of-care glucose testing in hospitals remains a vital segment.
What are the key market drivers leading to the rise in the adoption of Blood Glucose Monitoring System Industry?
- The expansion of reimbursement policies for blood glucose monitoring devices is a primary factor driving market adoption.
The availability of reimbursement for glucose meters is a significant factor influencing the market. These policies help mitigate the financial burden on patients, as monitoring devices can be costly and often need replacement. With some federal health insurance programs reimbursing approximately 80 percent of the cost for diagnosed individuals, access to necessary glycemic management tools is broadened. Such financial support structures are pivotal for increasing the adoption of glucose monitoring technologies and improving patient adherence to treatment regimens. This framework positively impacts device sales and encourages wider use of both self-monitoring systems and continuous glucose monitors.The growing prevalence of diabetes globally creates a persistent and expanding need for blood glucose monitoring systems. As the number of individuals diagnosed with both type 1 and type 2 diabetes increases due to factors such as aging populations, lifestyle changes, and rising obesity levels, so does the demand for effective glycemic control tools. This demographic shift makes diabetes management a critical public health priority, driving continuous demand for accurate and user-friendly monitoring technologies. The expanding patient pool necessitates innovative solutions that help individuals manage their condition effectively to prevent long-term complications and reduce healthcare system costs.
What are the market trends shaping the Blood Glucose Monitoring System Industry?
- A significant market trend is the increasing adoption of continuous glucose monitoring (CGM) systems, which offer real-time tracking and enhanced user convenience.
A prominent trend shaping the industry is the rising demand for continuous glucose monitoring (CGM) systems, particularly for insulin-dependent patients. Unlike traditional self-monitoring devices, CGM solutions offer significant advantages, including being less invasive, providing real-time tracking of glucose fluctuations, and delivering faster, more precise results for improved glycemic management. This focus on enhancing patient convenience and data accessibility is driving strong adoption across diverse patient groups. The industry is also increasingly investing in the development of non-invasive glucose monitoring devices, reflecting a clear shift toward technologies that reduce the daily burden of diabetes care.Companies are increasingly adopting a bundled product marketing strategy to enhance value and customer retention. This approach involves packaging blood glucose monitoring devices with complementary products and services, such as digital health applications, personalized coaching, and supplies like test strips. By creating an integrated ecosystem, this strategy transforms a standalone device into a comprehensive diabetes management solution. This model improves user engagement and provides holistic support, fostering long-term loyalty. This strategy is particularly effective in competitive landscapes, with some regions like North America representing over 44% of the geographic opportunity, where differentiation is key.
What challenges does the Blood Glucose Monitoring System Industry face during its growth?
- A key challenge impeding market growth is the low rate of diabetes diagnosis and subsequent treatment, particularly in emerging economies.
A major challenge impacting the market is the low rate of diabetes diagnosis and treatment, especially in emerging nations. A substantial portion of the population with the condition remains undiagnosed due to a lack of public awareness and the absence of structured government or commercial screening programs. In certain regions, it is estimated that more than 60 percent of individuals with diabetes are unaware of their condition. This situation is worsened by limited access to advanced healthcare infrastructure and a lack of reimbursement frameworks, which together restrict the uptake of both self-monitoring and continuous glucose monitoring systems.The high cost of blood glucose monitoring systems and their associated supplies presents a significant barrier to widespread adoption. While basic meters may be affordable, the recurring expense of test strips, lancets, and particularly the sensors for continuous glucose monitoring (CGM) systems can be prohibitive for many individuals. This financial challenge is more acute for patients without comprehensive insurance coverage or in regions where reimbursement policies are limited or non-existent. The high cost restricts access to optimal glycemic management tools, preventing many from benefiting from advanced technologies that could improve health outcomes and quality of life.
Exclusive Customer Landscape
The blood glucose monitoring system market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the blood glucose monitoring system market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, blood glucose monitoring system market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - Offerings within the market consist of integrated blood glucose monitoring systems that provide a variety of features tailored to address the specific daily management requirements of individuals with diabetes. These systems are designed to improve user experience and facilitate better data accessibility for effective glycemic control. The focus is on delivering reliable and convenient solutions that fit into the user's lifestyle, enabling more informed health decisions through accurate and timely glucose measurement. These products often form part of a broader digital health ecosystem, connecting with applications and platforms to offer a holistic view of an individual's metabolic health status.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Abbott Laboratories
- ACON Laboratories Inc.
- ARKRAY Inc.
- B.Braun SE
- Dexcom Inc.
- DiaMonTech AG
- F. Hoffmann La Roche Ltd.
- GlySens Inc.
- i-SENS, Inc.
- Indigo Diabetes NV
- Intuity Medical Inc.
- Koninklijke Philips NV
- LifeScan IP Holdings LLC
- Medtronic Plc
- Nipro Corp.
- Ok Biotech Co Ltd.
- PHC Holdings Corp.
- Prodigy Diabetes Care LLC
- WaveForm Technologies Inc.
- Ypsomed Holding AG
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Blood Glucose Monitoring System Market
In March 2024, Dexcom Inc. received clearance from the U.S. Food and Drug Administration for its Stelo Glucose Biosensor System, the first continuous glucose monitor to be approved for over-the-counter use without a prescription.In May 2024, Abbott Laboratories presented new research demonstrating the accuracy and reliability of its FreeStyle Libre 2 system for use in the general hospital population, supporting its expansion into inpatient care settings.In June 2023, Dexcom Inc. announced the submission of its G7 Continuous Glucose Monitoring System to the U.S. Food and Drug Administration for review for use in the hospital setting, signaling a strategic move to establish CGM as a standard of care in inpatient environments.
Research Analyst Overview
The global blood glucose monitoring system market is experiencing a significant transformation as conventional self-monitoring blood glucose methods evolve. The integration of advanced biosensor technology is redefining diabetes management solutions, moving beyond intermittent checks with home glucose meters. The market dynamic now favors continuous glucose monitoring systems, which offer real-time tracking of glycemic levels. This shift facilitates a deeper understanding of glucose fluctuations, supporting more effective glycemic control. Wearable glucose sensors are central to this evolution, enabling patients to actively manage their metabolic health monitoring with greater precision and data accessibility. The industry anticipates this segment to represent a substantial portion of market expansion, with projections indicating a potential 12% increase in adoption over the next several years.Building on enhanced data collection, the market is advancing toward integrated diabetes care platforms. The focus is shifting to automated insulin delivery and the development of closed-loop systems, which depend heavily on insulin pump integration and superior sensor accuracy. These systems leverage glucose trend analysis for proactive hypoglycemia detection and hyperglycemia alerts, improving patient safety. This evolution is fostering comprehensive digital health ecosystems and glucose data platforms that utilize metrics like the time in range metric. Concurrently, research into non-invasive monitoring, implantable glucose monitors, and microneedle sensor patches indicates the ongoing pursuit of less intrusive and more seamless remote patient monitoring, aiming to improve glycemic management and overall patient adherence.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Blood Glucose Monitoring System Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
284
|
|
Base year
|
2024
|
|
Historic period
|
2019 - 2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerating at a CAGR of 10.0%
|
|
Market growth 2024-2029
|
USD 10.1 billion
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2029(%)
|
8.9%
|
|
Key countries
|
US, Canada, Mexico, Germany, UK, France, Italy, The Netherlands, Spain, Japan, China, India, South Korea, Indonesia, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, South Africa, Israel, Turkey
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Blood Glucose Monitoring System Market Research and Growth Report?
- CAGR of the Blood Glucose Monitoring System industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the blood glucose monitoring system market growth of industry companies
We can help! Our analysts can customize this blood glucose monitoring system market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Indication
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Chart on Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Chart on Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Chart on Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3 Market Landscape
- 3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Chart on Market characteristics analysis
- 3.3 Value chain analysis
- Chart on Value chain analysis
4 Market Sizing
- 4 Market Sizing
- 4.1 Market definition
- Data Table on Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5 Historic Market Size
- 5.1 Global Blood Glucose Monitoring System Market 2019 - 2023
- Historic Market Size - Data Table on Global Blood Glucose Monitoring System Market 2019 - 2023 ($ billion)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ billion)
- 5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
- 5.4 Indication segment analysis 2019 - 2023
- Historic Market Size - Indication Segment 2019 - 2023 ($ billion)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
- 6 Qualitative Analysis
- 6.1 Impact of AI on the global blood glucose monitoring system market
7 Five Forces Analysis
- 7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 Self monitoring - Market size and forecast 2024-2029
- Chart on Self monitoring - Market size and forecast 2024-2029 ($ billion)
- Data Table on Self monitoring - Market size and forecast 2024-2029 ($ billion)
- Chart on Self monitoring - Year-over-year growth 2024-2029 (%)
- Data Table on Self monitoring - Year-over-year growth 2024-2029 (%)
- 8.4 Continuous glucose monitoring devices - Market size and forecast 2024-2029
- Chart on Continuous glucose monitoring devices - Market size and forecast 2024-2029 ($ billion)
- Data Table on Continuous glucose monitoring devices - Market size and forecast 2024-2029 ($ billion)
- Chart on Continuous glucose monitoring devices - Year-over-year growth 2024-2029 (%)
- Data Table on Continuous glucose monitoring devices - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ billion)
- Data Table on Market opportunity by Product ($ billion)
9 Market Segmentation by End-user
- 9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Hospitals - Market size and forecast 2024-2029
- Chart on Hospitals - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hospitals - Market size and forecast 2024-2029 ($ billion)
- Chart on Hospitals - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals - Year-over-year growth 2024-2029 (%)
- 9.4 Home care - Market size and forecast 2024-2029
- Chart on Home care - Market size and forecast 2024-2029 ($ billion)
- Data Table on Home care - Market size and forecast 2024-2029 ($ billion)
- Chart on Home care - Year-over-year growth 2024-2029 (%)
- Data Table on Home care - Year-over-year growth 2024-2029 (%)
- 9.5 Diagnostic centers - Market size and forecast 2024-2029
- Chart on Diagnostic centers - Market size and forecast 2024-2029 ($ billion)
- Data Table on Diagnostic centers - Market size and forecast 2024-2029 ($ billion)
- Chart on Diagnostic centers - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostic centers - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by End-user
- Market opportunity by End-user ($ billion)
- Data Table on Market opportunity by End-user ($ billion)
10 Market Segmentation by Indication
- 10 Market Segmentation by Indication
- 10.1 Market segments
- Chart on Indication - Market share 2024-2029 (%)
- Data Table on Indication - Market share 2024-2029 (%)
- 10.2 Comparison by Indication
- Chart on Comparison by Indication
- Data Table on Comparison by Indication
- 10.3 Type-2 diabetes population - Market size and forecast 2024-2029
- Chart on Type-2 diabetes population - Market size and forecast 2024-2029 ($ billion)
- Data Table on Type-2 diabetes population - Market size and forecast 2024-2029 ($ billion)
- Chart on Type-2 diabetes population - Year-over-year growth 2024-2029 (%)
- Data Table on Type-2 diabetes population - Year-over-year growth 2024-2029 (%)
- 10.4 Type-1 diabetes population - Market size and forecast 2024-2029
- Chart on Type-1 diabetes population - Market size and forecast 2024-2029 ($ billion)
- Data Table on Type-1 diabetes population - Market size and forecast 2024-2029 ($ billion)
- Chart on Type-1 diabetes population - Year-over-year growth 2024-2029 (%)
- Data Table on Type-1 diabetes population - Year-over-year growth 2024-2029 (%)
- 10.5 Market opportunity by Indication
- Market opportunity by Indication ($ billion)
- Data Table on Market opportunity by Indication ($ billion)
11 Customer Landscape
- 11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- 12.3.1 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.3.2 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.3.3 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ billion)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ billion)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- 12.4.1 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.4.2 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.4.3 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.4.4 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 12.4.5 The Netherlands - Market size and forecast 2024-2029
- Chart on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Data Table on The Netherlands - Market size and forecast 2024-2029 ($ billion)
- Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
- Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
- 12.4.6 Spain - Market size and forecast 2024-2029
- Chart on Spain - Market size and forecast 2024-2029 ($ billion)
- Data Table on Spain - Market size and forecast 2024-2029 ($ billion)
- Chart on Spain - Year-over-year growth 2024-2029 (%)
- Data Table on Spain - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- 12.5.1 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.5.2 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.5.3 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.5.4 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.5.5 Indonesia - Market size and forecast 2024-2029
- Chart on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Indonesia - Market size and forecast 2024-2029 ($ billion)
- Chart on Indonesia - Year-over-year growth 2024-2029 (%)
- Data Table on Indonesia - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- 12.6.1 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Australia - Market size and forecast 2024-2029 ($ billion)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 12.6.2 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.6.3 Argentina - Market size and forecast 2024-2029
- Chart on Argentina - Market size and forecast 2024-2029 ($ billion)
- Data Table on Argentina - Market size and forecast 2024-2029 ($ billion)
- Chart on Argentina - Year-over-year growth 2024-2029 (%)
- Data Table on Argentina - Year-over-year growth 2024-2029 (%)
- 12.6.4 Colombia - Market size and forecast 2024-2029
- Chart on Colombia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Colombia - Market size and forecast 2024-2029 ($ billion)
- Chart on Colombia - Year-over-year growth 2024-2029 (%)
- Data Table on Colombia - Year-over-year growth 2024-2029 (%)
- 12.6.5 Saudi Arabia - Market size and forecast 2024-2029
- Chart on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Saudi Arabia - Market size and forecast 2024-2029 ($ billion)
- Chart on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2024-2029 (%)
- 12.6.6 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ billion)
- Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.6.7 South Africa - Market size and forecast 2024-2029
- Chart on South Africa - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Africa - Market size and forecast 2024-2029 ($ billion)
- Chart on South Africa - Year-over-year growth 2024-2029 (%)
- Data Table on South Africa - Year-over-year growth 2024-2029 (%)
- 12.6.8 Israel - Market size and forecast 2024-2029
- Chart on Israel - Market size and forecast 2024-2029 ($ billion)
- Data Table on Israel - Market size and forecast 2024-2029 ($ billion)
- Chart on Israel - Year-over-year growth 2024-2029 (%)
- Data Table on Israel - Year-over-year growth 2024-2029 (%)
- 12.6.9 Turkey - Market size and forecast 2024-2029
- Chart on Turkey - Market size and forecast 2024-2029 ($ billion)
- Data Table on Turkey - Market size and forecast 2024-2029 ($ billion)
- Chart on Turkey - Year-over-year growth 2024-2029 (%)
- Data Table on Turkey - Year-over-year growth 2024-2029 (%)
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ billion)
- Data Tables on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
- 13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Availability of reimbursement for BGM devices
- Growing prevalence of diabetes
- Increasing number of product launches
- 13.2 Market challenges
- Lower diagnosis and treatment rate
- High cost of blood glucose monitoring systems and supplies
- Intense competition among companies
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities
- Rising demand for continuous blood glucose monitoring (CGM) devices
- Increased adoption of bundled product marketing strategy
- Growing number of strategic developments
14 Competitive Landscape
- 14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 15.5 ARKRAY Inc.
- ARKRAY Inc. - Overview
- ARKRAY Inc. - Product / Service
- ARKRAY Inc. - Key offerings
- SWOT
- 15.6 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key news
- B.Braun SE - Key offerings
- SWOT
- 15.7 Dexcom Inc.
- Dexcom Inc. - Overview
- Dexcom Inc. - Product / Service
- Dexcom Inc. - Key offerings
- SWOT
- 15.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.9 i-SENS, Inc.
- i-SENS, Inc. - Overview
- i-SENS, Inc. - Product / Service
- i-SENS, Inc. - Key offerings
- SWOT
- 15.10 Indigo Diabetes NV
- Indigo Diabetes NV - Overview
- Indigo Diabetes NV - Product / Service
- Indigo Diabetes NV - Key offerings
- SWOT
- 15.11 Intuity Medical Inc.
- Intuity Medical Inc. - Overview
- Intuity Medical Inc. - Product / Service
- Intuity Medical Inc. - Key offerings
- SWOT
- 15.12 Koninklijke Philips NV
- Koninklijke Philips NV - Overview
- Koninklijke Philips NV - Business segments
- Koninklijke Philips NV - Key news
- Koninklijke Philips NV - Key offerings
- Koninklijke Philips NV - Segment focus
- SWOT
- 15.13 LifeScan IP Holdings LLC
- LifeScan IP Holdings LLC - Overview
- LifeScan IP Holdings LLC - Product / Service
- LifeScan IP Holdings LLC - Key offerings
- SWOT
- 15.14 Medtronic Plc
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key news
- Medtronic Plc - Key offerings
- Medtronic Plc - Segment focus
- SWOT
- 15.15 Nipro Corp.
- Nipro Corp. - Overview
- Nipro Corp. - Business segments
- Nipro Corp. - Key offerings
- Nipro Corp. - Segment focus
- SWOT
- 15.16 PHC Holdings Corp.
- PHC Holdings Corp. - Overview
- PHC Holdings Corp. - Business segments
- PHC Holdings Corp. - Key offerings
- PHC Holdings Corp. - Segment focus
- SWOT
- 15.17 Prodigy Diabetes Care LLC
- Prodigy Diabetes Care LLC - Overview
- Prodigy Diabetes Care LLC - Product / Service
- Prodigy Diabetes Care LLC - Key offerings
- SWOT
- 15.18 Ypsomed Holding AG
- Ypsomed Holding AG - Overview
- Ypsomed Holding AG - Business segments
- Ypsomed Holding AG - Key offerings
- Ypsomed Holding AG - Segment focus
- SWOT
16 Appendix
- 16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
